Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MIRM
#1088
Mirum Pharmaceuticals, Inc. - common stock
119.0
4
USD
-0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.53%
Monthly Change
+19.65%
6 month change
+30.83%
Year Change
+69.74%
Previous Close
122.1
3
Open
119.0
4
Low
119.0
4
High
119.0
4
Volume
90
Markets
US Stock Market
Healthcare
Biotechnology
MIRM
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
30.42 M
31.73 M
37.95 M
47 M
49.01 M
60.34 M
60.98 M
Valuation ratios
Enterprise value
389.04 M
474.76 M
703.69 M
1.43 B
2.11 B
4.78 B
7.8 B
Price to earnings ratio
—
—
-4.8
-7.5
-22.35
-168.06
-9.43
Price to sales ratio
—
—
8.5
6.59
5.83
7.61
12.11
Price to cash flow ratio
—
—
-5.45
17.3
190.32
71.03
-45.34
Price to book ratio
—
—
4.61
4.94
8.71
12.6
6.21
Enterprise value to EBITDA ratio
—
-2.75
-5.5
-14.56
-33.02
2 267.31
-10.12
Profitability ratios
Return on assets %
-0.43
-0.29
-0.38
-0.25
-0.13
-0.03
-0.89
Return on equity %
-0.6
-0.7
-0.96
-0.66
-0.39
-0.07
-3.26
Return on invested capital %
-2 442.39
-1 010.86
-339.27
-197.68
-125.01
-32.94
-843.13
Gross margin %
—
100
100
100
100
100
100
Operating margin %
—
-906.12
-170.28
-58.57
-26
-4.25
-493.78
EBITDA margin %
—
-903.01
-166.08
-52.76
-18.99
0.4
-489.48
Net margin %
—
-438.85
-176.05
-87.68
-26.1
-4.48
-494.21
Liquidity ratios
Quick ratio
—
3.88
2.85
4.19
2.93
2.55
1.99
Current ratio
12.8
3.91
2.94
4.45
3.1
2.67
2.09
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.07
0.24
0.37
0.51
0.62
0.18
Solvency ratios
Debt to assets ratio
—
—
—
0.47
0.46
0.37
0.35
Debt to equity ratio
—
—
—
1.23
1.37
0.98
1.28
Long term debt to total assets ratio
—
—
—
0.47
0.46
0.37
0.35
Long term debt to total equity ratio
—
—
—
1.23
1.37
0.98
1.28
Per share metrics
Operating cash flow per share
—
—
-3.54
-1.74
0.22
1.11
-2.83
EBIT per share
—
—
-3.86
-2.67
-1.84
-0.44
-13.56
EBITDA per share
—
—
-3.77
-2.4
-1.35
0.04
-13.09
Total debt per share
—
—
—
7.49
6.48
6.17
5.27
Cash per share
—
—
4.46
7
5.9
7.64
6.56
Net current asset value per share
—
—
5.6
9.48
8.27
10.95
9.68
Tangible book value per share
—
—
4.18
6.08
4.75
6.27
4.12
Working capital per share
—
—
3.69
7.35
5.6
6.85
5.04
Book value per share
—
—
4.18
6.08
4.75
6.27
4.12
News
Stocks To Watch: 14 Names Test And Tease New Buy Zones
SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)
Mirum Pharmaceuticals: This Liver Disease Juggernaut Broadened Its Portfolio (NASDAQ:MIRM)
Morgan Stanley, Dell, Other Rising Leaders Join IBD Top Stock Screens
AI Play And Memory-Chip Maker Micron Among 17 Newcomers To Today's Best Growth Stock Lists
INCY Stock Hits 52-Week High on Regulatory Updates for Opzelura
Strength Seen in Mirum Pharmaceuticals (MIRM): Can Its 5.5% Jump Turn into More Strength?
Lilly Hits Record High Amid Massive Profit Growth, Leads 28 Just Added To Best Stock Lists
MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)
MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)
MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review
Why Is Mirum Pharmaceuticals (MIRM) Down 10.1% Since Last Earnings Report?